Ledger.Open graph →
SEC Form D · filed March 27, 2019

Prellis Biologics, Inc

Offering
$9.2M
Sold
$8.7M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Arvind Gupta · San Francisco, CADirectorMelanie Matheu · San Francisco, CAExec · DirectorRohit Sharma · San Francisco, CADirectorDaniel J. Mavico · Charlotte, NCDirectorPaul Hallenbeck · Blue Bell, PADirectorAdam Taback · Charlotte, NCExec · DirectorMarco Alfonsi · HICKSVILLE, NYDirectorNitesh Kumar · Princeton, NJExec · DirectorLongTail Alpha LLC · Newport Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗